All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @kellyferrobeauty on TikTok · 40s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @kellyferrobeauty's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Let's talk about my current stack. This one is a good one. As you guys know with peptides,
  2. 0:04we cycle some of these. For the first one, this one is orange. It's 5 amino cute. This is the
  3. 0:09first day that I'm taking this. So I'm going to let you guys know the update. It's energy,
  4. 0:13recovery, and overall vitality. Mott C. This one is energy metabolism overall cellular function.
  5. 0:20I need this one today. This is C-Max. This is for mental clarity, focus, cognitive performance,
  6. 0:25right here. You guys end in a noodle. And then you have my copper peptide, which is skin, hair,
  7. 0:29nails, and it does so much more. I know it looks like a lot, but I added extra of this in the noodle,
  8. 0:35so it won't sting. It's a little trick. Let me know what your current stack is.

@kellyferrobeauty's peptide stack claims, fact-checked

KellyFerroShop

TikTok creator

21.6K viewsWatch on TikTok

Quick answer

The creator is self-administering a multi-compound stack that includes two compounds (MOTS-c and Semax) with no FDA-approved human therapeutic indication in the U.S., one small molecule (5-Amino-1MQ) with only preclinical data, and GHK-Cu, which has the strongest published evidence base of the group but is still not approved as a therapeutic drug. No dosing, sourcing, or supervising clinician is mentioned, which makes it impossible to assess safety or appropriateness for any individual viewer. Stacking multiple investigational compounds simultaneously significantly complicates any assessment of efficacy or adverse effects.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksGHK-Cu (Copper Peptide)Provider discussion

Evidence signal

Source-backed review

Regulatory reality

GHK-Cu (Copper Peptide) access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @kellyferrobeauty's peptide stack claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

GHK-Cu (Copper Peptide) is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this ghk-cu video claims cluster

Best for searchers checking whether GHK-Cu beauty and recovery claims match the evidence base.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@kellyferrobeauty's peptide stack claims, fact-checked" from KellyFerroShop. We read the clip as a Peptide social video fact-checks claim about GHK-Cu (Copper Peptide), then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is self-administering a multi-compound stack that includes two compounds (MOTS-c and Semax) with no FDA-approved human therapeutic indication in the U.

The reason this review is not generic is the source wording and the canonical claim label "peptides share your stack peptidetherapy mots 5am semax g." In this clip, the useful excerpt is: "Let's talk about my current stack." That wording changes the review because it points to GHK-Cu (Copper Peptide) safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging (2015), Effects of glycyl-histidyl-lysine-Cu on wound healing (Search), and Copper peptide and skin remodeling literature (Search), plus the creator's own wording. GHK-Cu (Copper Peptide) still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

MOTS-c's best evidence comes from a 2021 Nature Communications mouse study.
People who land here are usually comparing the GHK-Cu (Copper Peptide) claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GHK-Cu (Copper Peptide) guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is self-administering a multi-compound stack that includes two compounds (MOTS-c and Semax) with no FDA-approved human therapeutic indication in the U.

FormBlends verdict

GHK-Cu (Copper Peptide) safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the GHK-Cu (Copper Peptide) guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is self-administering a multi-compound stack that includes two compounds (MOTS-c and Semax) with no FDA-approved human therapeutic indication in the U.S., one small molecule (5-Amino-1MQ) with only preclinical data, and GHK-Cu, which has the strongest published evidence base of the group but is still not approved as a therapeutic drug. No dosing, sourcing, or supervising clinician is mentioned, which makes it impossible to assess safety or appropriateness for any individual viewer. Stacking multiple investigational compounds simultaneously significantly complicates any assessment of efficacy or adverse effects.
  • 5-Amino-1MQ is a small synthetic molecule, not a peptide. Calling it part of a peptide stack is a category error with no clinical basis.
  • MOTS-c's best evidence comes from a 2021 Nature Communications mouse study. No large-scale human RCTs have confirmed the metabolic and energy claims made in the video.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • GHK-Cu (Copper Peptide) decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the GHK-Cu (Copper Peptide) guide, cost path, safety notes, and provider review before acting.

Review GHK-Cu (Copper Peptide)

What You'll Learn

  • 5-Amino-1MQ is a small synthetic molecule, not a peptide. Calling it part of a peptide stack is a category error with no clinical basis.
  • MOTS-c's best evidence comes from a 2021 Nature Communications mouse study. No large-scale human RCTs have confirmed the metabolic and energy claims made in the video.
  • Semax was developed in Russia and has limited peer-reviewed human data available in Western medical literature. Its cognitive performance claims rest primarily on rodent models.
  • GHK-Cu is the most evidence-supported compound in this stack, with published reviews on skin remodeling (Pickart and Margolina, 2018), but it is still not FDA-approved as a therapeutic drug.
  • None of these compounds are FDA-approved for the indications described. Self-sourced, unmonitored stacking introduces contamination risk, unknown dosing variance, and no safety oversight.
  • Stacking multiple investigational compounds simultaneously makes it nearly impossible to attribute effects or adverse events to any single compound, a basic problem that clinical trials spend millions trying to control for.
  • A licensed clinician reviewing labs and health history before starting any peptide protocol is not optional caution. It is the minimum standard for responsible use of investigational compounds.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @kellyferrobeauty actually say?

Kelly walked through five peptides she takes as part of a rotating "stack." She described "5 amino cute" (almost certainly 5-Amino-1MQ) as supporting energy, recovery, and overall vitality. She called MOTS-c a tool for "energy metabolism overall cellular function." Semax, she said, is for "mental clarity, focus, cognitive performance." GHK-Cu she framed as a copper peptide good for "skin, hair, nails, and it does so much more." She also mentioned mixing an extra dose of GHK-Cu into a "noodle" solution to reduce injection sting. What she did not mention: dosing, sourcing, frequency, or that most of these compounds are not FDA-approved for human use. That omission matters enormously when 21,000 people are watching and potentially shopping for what she is holding up on camera.

Does the science back this up?

Partially, but the evidence base is thinner than a TikTok will ever admit. MOTS-c has legitimate early research behind it. A 2021 paper by Lee et al. in Nature Communications showed MOTS-c improved metabolic function and physical performance in aged mice, and some human pharmacokinetic data exists, but no large randomized controlled trials in humans have confirmed the metabolic claims she is making. Semax has a more interesting research record: it was developed in Russia and has peer-reviewed work (Dolotov et al., 2006, Behavioural Brain Research) suggesting neuroprotective and nootropic effects in rodent models, but human clinical data is limited largely to Russian medical literature. GHK-Cu is arguably the best-supported compound here. Pickart and Margolina (2018, Symmetry) reviewed substantial evidence for GHK-Cu's role in skin remodeling and wound healing. 5-Amino-1MQ, a small molecule NNMT inhibitor, has early preclinical data on fat metabolism and NAD+ pathways (Neelakantan et al., 2019, Nature Communications), but calling it an established "vitality" compound is a significant leap from the current evidence.

What did they get wrong (or right)?

She got the general mechanism descriptions roughly in the right neighborhood, which is more than many peptide influencers do. Calling MOTS-c an energy metabolism compound is directionally accurate based on its mitochondrial origins. Framing GHK-Cu as a skin and tissue peptide is well-supported. Credit where it is due.

What she got wrong, or at least glossed over:

  • "5 amino cute" is not a peptide at all. It is a small synthetic molecule, not a bioactive peptide chain. Lumping it in a "peptide stack" is a category error.
  • Her Semax claim about cognitive performance is plausible in animal models but she presented it as settled fact. It is not.
  • The "so much more" framing around GHK-Cu is vague enough to imply systemic disease benefit without saying it, which is how influencer health content often skirts compliance lines.
  • She never mentioned that cycling peptides without medical oversight carries real risk of misuse, contamination from non-pharmaceutical-grade sources, and unknown interaction effects.

What should you actually know?

None of these compounds are FDA-approved drugs for the indications she described. Some, including MOTS-c and Semax, are not approved for any human therapeutic use in the United States. That does not mean the research is worthless, but it does mean there is no standardized dosing, no required purity testing, and no regulatory body ensuring what is in the vial matches what is on the label. Compounded peptides from telehealth platforms operate under different oversight than this kind of unregulated self-sourcing implies.

The "sting reduction" tip she offers for GHK-Cu is anecdotal. There is no published evidence that diluting in a different vehicle reduces local irritation in a clinically meaningful way. It may be harmless, but framing it as a confirmed trick misleads viewers into thinking self-injection optimization is straightforward.

If you are curious about any of these compounds, the appropriate starting point is a licensed clinician who can review your labs, your health history, and the actual evidence, not a 60-second TikTok from someone whose sourcing and dosing are never disclosed.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

KellyFerroShop · TikTok creator

21.6K views on this video

Share your stack! 🦄🧬 #peptidetherapy #mots #5am #semax #ghkcu

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about 5-amino-1mq?

5-Amino-1MQ is a small synthetic molecule, not a peptide. Calling it part of a peptide stack is a category error with no clinical basis.

What does the video say about mots-c's best evidence comes from a 2021 nature communications mouse?

MOTS-c's best evidence comes from a 2021 Nature Communications mouse study. No large-scale human RCTs have confirmed the metabolic and energy claims made in the video.

What does the video say about semax was developed in russia?

Semax was developed in Russia and has limited peer-reviewed human data available in Western medical literature. Its cognitive performance claims rest primarily on rodent models.

What does the video say about ghk-cu?

GHK-Cu is the most evidence-supported compound in this stack, with published reviews on skin remodeling (Pickart and Margolina, 2018), but it is still not FDA-approved as a therapeutic drug.

What does the video say about none of these compounds?

None of these compounds are FDA-approved for the indications described. Self-sourced, unmonitored stacking introduces contamination risk, unknown dosing variance, and no safety oversight.

What does the video say about stacking multiple investigational compounds simultaneously makes it nearly impossible to?

Stacking multiple investigational compounds simultaneously makes it nearly impossible to attribute effects or adverse events to any single compound, a basic problem that clinical trials spend millions trying to control for.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by KellyFerroShop, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.